Zevra Therapeutics Inc
F:1GDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
F:1GDA
|
US |
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
Mediobanca Banca di Credito Finanziario SpA
F:ME90
|
IT |
|
Nurexone Biologic Inc
F:J90
|
CA |
|
L
|
Lynas Rare Earths Ltd
F:LYI
|
MY |
|
Bally's Corp
F:358
|
US |
|
L
|
Lockheed Martin Corp
DUS:LOM
|
US |
|
Capital Southwest Corp
F:SFW
|
US |
|
I
|
International Business Machines Corp
DUS:IBM
|
US |
|
P
|
PALTAC Corp
OTC:PCCOF
|
JP |
|
A
|
Anglo American Platinum Ltd
SWB:RPHA
|
ZA |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
F:SAJA
|
BR |
|
B
|
BlackRock Inc
XBER:BLQA
|
US |
|
D
|
Danone SA
DUS:BSN
|
FR |
|
M
|
MMG Ltd
F:OMS1
|
AU |
|
Magis SpA
F:ZF6
|
IT |
|
P
|
Pernod Ricard SA
DUS:PER
|
FR |
|
Bloom Energy Corp
NYSE:BE
|
US |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
Nice Ltd
F:NSY
|
IL |
|
K
|
Koninklijke Philips NV
XMUN:PHI1
|
NL |
|
E
|
Ecolab Inc
XMUN:ECJ
|
US |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
S
|
Sun Hung Kai Properties Ltd
F:SHG
|
HK |
Wall St Price Targets
1GDA Price Targets Summary
Zevra Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 1GDA is 19.53 EUR with a low forecast of 14.97 EUR and a high forecast of 22.48 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1GDA's stock price target?
Price Target
19.53
EUR
According to Wall Street analysts, the average 1-year price target for 1GDA is 19.53 EUR with a low forecast of 14.97 EUR and a high forecast of 22.48 EUR.
What is the Revenue forecast for Zevra Therapeutics Inc?
Projected CAGR
19%
The compound annual growth rate for Revenue over the next 8 years is 19%.
What is the Net Income forecast for Zevra Therapeutics Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 8 years is 15%.
